Patients undergoing primary total knee arthroplasty (TKA) for osteoarthritis, who had never used opioids, were retrospectively selected. Using age (6 years), BMI (5), and sex, 186 patients who underwent cementless total knee arthroplasty (TKA) were paired with 16 patients who received cemented total knee arthroplasty (TKA). We examined inhospital pain scores, 90-day opioid utilization expressed in morphine milligram equivalents (MMEs), and early postoperative PROMs.
The numeric rating scale pain scores were consistent across cemented and cementless cohorts; demonstrating similar lowest (009 vs 008), highest (736 vs 734), and average (326 vs 327) values, confirming no statistically significant difference (P > .05). Insensitivity in the hospital was found to be similar (90 versus 102, P = .176). A statistical analysis of discharge (315 vs 315) revealed a p-value of .483, Analyzing the total counts of 687 versus 720 revealed a probability of .547. Cellular network operations are contingent upon the proper functioning of MMEs. A comparable average hourly opioid consumption was observed in both groups of inpatients, at 25 MMEs per hour (P = .965). In both groups, the average number of refills during the 90 days following surgery was similar. One group averaged 15 refills, the other 14, and this difference was statistically insignificant (P = .893). The cemented and cementless cohorts displayed comparable PROMs scores at preoperative, 6-week, 3-month, 6-week change, and 3-month change time points (P > 0.05). A matched study comparing cemented and cementless total knee arthroplasties (TKAs) demonstrated identical in-hospital pain scores, opioid utilization, total medication management equivalents (MMEs) within 90 days, and patient-reported outcome measures (PROMs) at six and three months postoperatively.
Retrospective cohort study, designated as III.
Retrospective cohort study, looking back at past groups.
Investigations into substance use patterns indicate a growing number of individuals using both tobacco and cannabis. Neurological infection We examined the cohort of tobacco, cannabis, and combined substance users who underwent a primary total knee arthroplasty (TKA) to identify their risk for (1) periprosthetic joint infection; (2) the likelihood of needing a revision; and (3) related medical complications within 90 days to 2 years post-surgery.
Patients who underwent primary total knee arthroplasty (TKA) procedures were identified from a national, all-payer database spanning the years 2010 through 2020. Current substance use—tobacco, cannabis, or a combination—determined patient stratification into three groups with 30,000, 400, and 3,526 participants, respectively. These were categorized using the criteria from the International Classification of Diseases, Ninth and Tenth Editions. Patients' trajectories were scrutinized for the two years leading up to TKA and the next two years that followed. The fourth group of TKA recipients, abstaining from both tobacco and cannabis, constituted a matched cohort. Search Inhibitors From 90 days to 2 years post-procedure, bivariate analyses were used to evaluate Periprosthetic joint infections (PJIs), revisions, and other medical/surgical complications in these two cohorts. Multivariate analyses, taking into account patient demographics and health metrics, determined independent risk factors for PJI from 90 days up to 2 years.
The combined consumption of tobacco and cannabis was associated with the most frequent development of prosthetic joint infection (PJI) subsequent to total knee replacement surgery (TKA). check details Among cannabis, tobacco, and combined users, the likelihood of a 90-day postoperative infectious complication (PJI) was 160, 214, and 339, respectively, when compared to the matched control group (P < .001). Co-users demonstrated a dramatically elevated likelihood of requiring a revision two years after TKA, with an odds ratio reaching 152 (95% confidence interval 115-200). Following total knee arthroplasty (TKA) at 1 and 2 years, patients using cannabis, tobacco, or both experienced significantly higher rates of myocardial infarction, respiratory failure, surgical site infections, and anesthetic manipulations compared to a matched control group (all p < 0.001).
A compounded risk of periprosthetic joint infection (PJI) was observed in individuals utilizing both tobacco and cannabis before undergoing primary total knee arthroplasty (TKA), spanning from 90 days to two years after the procedure. In light of the well-understood harms of tobacco use, this additional knowledge about cannabis should be proactively addressed during the shared decision-making process prior to primary TKA surgery, thus optimizing patient preparation for potential risks post-operatively.
Patients using tobacco and cannabis before undergoing a primary total knee arthroplasty (TKA) showed a synergistic risk increase for prosthetic joint infection (PJI) from 90 days to two years after the surgery. Recognizing the well-documented harms associated with tobacco use, this new information about cannabis's possible influence should be a part of shared decision-making discussions preceding primary TKA, to best prepare for the anticipated post-operative recovery.
Variability is a notable feature of periprosthetic joint infection (PJI) management following total knee arthroplasty (TKA). To more accurately reflect contemporary approaches to PJI treatment, this study surveyed current American Association of Hip and Knee Surgeons (AAHKS) members to ascertain the distribution of operative techniques.
Of the 2752 AAHKS members, 844 completed an online survey with 32 multiple-choice questions on the management of PJI for TKA (31% response rate).
Private practice accounted for 50% of the membership, with 28% employed in an academic capacity. Averages show that members dealt with six to twenty PJI cases per calendar year. Among the patients, a two-stage exchange arthroplasty was performed in more than three-quarters of the cases. In excess of fifty percent of these cases, a cruciate-retaining (CR) or posterior-stabilized (PS) primary femoral component was employed, and in sixty-two percent of the cases, an all-polyethylene tibial implant was utilized. Vancomycin and tobramycin were the chosen antibiotics for a considerable number of members within the group. Every cement bag, irrespective of cement type, was augmented with 2 to 3 grams of antibiotics. Amphotericin stood out as the most prevalent antifungal choice when required. A significant degree of diversity characterized the post-operative management strategies, including variations in range of motion exercises, brace application protocols, and weight-bearing limitations.
Among the AAHKS participants, there was a range of responses regarding treatment, however, a notable preference surfaced for executing a two-stage exchange arthroplasty with an articulating spacer; a metal femoral component and all-polyethylene liner.
The AAHKS members presented differing viewpoints; however, a notable preference was for conducting a two-stage exchange arthroplasty using an articulating spacer, with a metal femoral component and an all-polyethylene liner.
Chronic periprosthetic infection following revision hip and knee arthroplasties has the potential to induce substantial femoral bone loss. A strategy for limb salvage in these cases is the resection of the residual femur and subsequent placement of an antibiotic-loaded total femoral spacer.
Between 2010 and 2019, a single-center, retrospective analysis evaluated 32 patients (median age 67 years, 15-93 years range, 18 female) who had undergone total femur spacer implantation for chronic periprosthetic joint infection with significant bone loss in the femur, all part of a planned two-stage exchange procedure. Over a period of 46 months (extending from 1 to 149 months), the median follow-up was observed. Utilizing Kaplan-Meier survival estimations, a study of implant and limb survival was conducted. An examination of potential failure risks was conducted.
The complication rate associated with the spacer was 34% (11 out of 32 patients), and 25% of those with complications required revision procedures. Post-initial stage, 92% were assessed as not having an infection. In 84% of instances, second-stage reimplantation of a total femoral arthroplasty involved the use of a modular megaprosthetic implant. Survival of implants without infection was 85% by two years, but only 53% after five years of operation. After a median of 40 months, a range from 2 to 110 months, 44% of patients experienced the need for amputation. In initial surgical operations, coagulase-negative staphylococci were frequently observed in cultures, but polymicrobial growth was more characteristic of reinfections.
In a high percentage (over 90%) of total femur spacer implementations, infection control is achieved, coupled with a tolerable rate of complications directly linked to the spacer. Following the second-stage megaprosthetic total femoral arthroplasty procedure, reinfection and subsequent amputation occur in approximately half of the cases.
Over 90% of cases employing total femur spacers achieve infection control, with a relatively low complication rate directly related to the spacer. Following a second-stage megaprosthetic total femoral arthroplasty, the incidence of reinfection, ultimately leading to amputation, is approximately 50%.
Chronic postsurgical pain (CPSP) following total knee and total hip arthroplasty (TKA and THA) is a noteworthy clinical issue, affected by a complex interplay of factors. The specific risk factors for CPSP in the aging demographic are currently unknown. As a result, our effort was focused on determining the prognostic indicators of CPSP arising from total knee and hip arthroplasty procedures, and offering support for early identification and intervention strategies for vulnerable elderly individuals at risk.
This prospective, observational study involved the gathering and analysis of data on 177 patients who underwent total knee arthroplasty (TKA) and 80 patients who underwent total hip arthroplasty (THA). Based on pain results at the 3-month follow-up, they were divided into the no chronic postsurgical pain and CPSP groups, respectively. A comparative analysis of preoperative baseline conditions, comprising pain intensity (Numerical Rating Scale) and sleep quality (Pittsburgh Sleep Quality Index), was conducted alongside a review of intraoperative and postoperative data.